Susan Richards

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Adele K. Fielding, Susan Richards, Rajesh Chopra et al. · Blood · 2006 · 843 citations · Full text

Medicine, Hematology, Oncology +9

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus et al. · Blood · 2007 · 782 citations · Full text

Medicine, Hematology, Oncology +16

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

David I. Marks, Elisabeth Paietta, Anthony V. Moorman et al. · Blood · 2009 · 416 citations · Full text

Medicine, Hematology, Oncology +17

Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease

Priya S. Kishnani, Deya Corzo, Nancy D. Leslie et al. · Pediatric Research · 2009 · 339 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +6

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

Adele K. Fielding, Jacob M. Rowe, Susan Richards et al. · Blood · 2009 · 288 citations · Full text

Medicine, Hematology, Oncology +16